Thousands of rheumatologists and health professionals rely on RheumNow for their daily dose of relevant news and information to keep them up-to-date and improve their practice. With the busy practitioner in mind, RheumNow consistently delivers rheumatology news, journal reports, social media highlights, and current opinions/perspectives from topic experts.
As part of its comprehensive meeting coverage, RheumNow’s faculty reporters and videographers are covering the 2018 EULAR Congress in Amsterdam. Coverage includes a combination of feature articles, news, video reports and interviews, speaker quotes, extensive tweeting and on-site photography. This annual meeting content is packaged on RheumNow’s annual meeting microsite: EULAR18.rheumnow.com.
RheumNow maintains all editorial control, and has final say over what is published. Sponsors/advertisers do not approve content or editorial coverage. RheumNow’s 2018 EULAR Congress coverage sponsor is Horizon Pharma.
2018 Faculty/Contributor Bios + Disclosures
Akerkar Shashank, MBBS, MD: Dr. Shashank is a rheumatologist practicing at Mumbai Arthritis Clinic and Research Centre in Bhandup West, Mumbai. You can follow him on Twitter at @doctorakerkar. Disclosure: Advisory board of J & J, Pfizer.
Ian Bruce, MD: Ian Bruce is a National Institute of Health Research (NIHR) Senior Investigator and Professor of Rheumatology at the Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, University of Manchester. He is Director of The NIHR Manchester Biomedical Research Centre. Professor Bruce qualified in medicine from Queen’s University Belfast in 1988 and gained his MRCP in 1991. He trained in medicine and rheumatology in Northern Ireland and completed his MD thesis on the pathogenesis of systemic vasculitis in 1995. He was the Geoff Carr Lupus Fellow at the University of Toronto, before moving to Manchester in 1998. Disclosure: Grants/Research Support: Genzyme/Sanofi, GSK, Roche, UCB. Consultant/Advisor Fees: Ely Lilly; GSK; Medimmune; Merck Serono; UCB. Participation in Speakers’ Bureau:
GSK; UCB. Honorarium: GSK; Roche; UCB; Medimmune.
Cassie Calabrese, DO: Dr. Calabrese is a fellow in rheumatology and infectious disease as part of a combined program at the Cleveland Clinic Foundation. She has a special interest in the intersection of rheumatology and infectious diseases. Follow her on Twitter: @CCalabreseDO. Disclosure: Nothing to disclose.
Jack Cush, MD: Dr. Cush is the Director of Clinical Rheumatology at the Baylor Research Institute and a Professor of Medicine and Rheumatology at Baylor University Medical Center in Dallas, TX. He is the Executive Editor of RheumNow.com and Co-Editor of the online textbook RheumaKnowledgy.com. Dr. Cush’s research and interests include novel drug development, rheumatoid arthritis, spondyloarthritis, drug safety, pregnancy and Still’s disease/autoinflammatory syndromes. He has published over 140 articles and 2 books in rheumatology. He can be followed on Twitter: @RheumNow. Disclosure: Investigator for – Abbvie, Astra-Zeneca, Genentech, Janssen, Novartis, Pfizer. Consultant/Advisor to Abbvie, Amgen, BMS, Celgene, Genentech, Horizon, Lilly, Novartis, UCB.
Kathryn Dao, MD: Dr. Dao the Associate Director of Clinical Rheumatology at Baylor Research Institute in Dallas. She is in clinical practice at the Arthritis Care and Research Center in Dallas, TX and is actively involved in patient care, medical education, and clinical research. Her interests include Rheumatoid Arthritis, Systemic Lupus Erythematosus, Gout, Infections with Biologics, Osteoporosis, and Drug Safety. She has served as the co-editor for the American College of Rheumatology “Drug Safety Quarterly” 2010-2013. Disclosure: Investigator for Abbvie, Astra-Zeneca, Genentech, Janssen, Novartis, Pfizer.
Julio Gonzalez, MD: Dr. Gonzalez is a rheumatologist currently serving as Medical Director of the Suncoast Medical Clinic Rheumatology-Dermatology Clinic, St. Anthony’s Infusion Center and Suncoast Medical Clinic Rheumatology Research Center, Comprehensive Research Institute, in Saint Petersburg, Florida. He also serves as Affiliate Assistant Professor, University of South Florida, Tampa, Florida. Disclosure: Speaking and advisory fees from Novartis, Pfizer, Abbvie. Advisory fees from Celgene.
Ronan Kavanagh, MD is a rheumatologist working in full time private practice in Galway, Ireland. He also writes a regular column for The Medical Independent (www.medicalindependent.ie) and runs an annual festival of medical curiosity called dotMED (www.dotmedconference.ie). Follow him on Twitter @ronantkavanagh.
Irwin Lim, MD: Irwin is a rheumatologist in private practice in Sydney. His other role is as a director of BJC Health. BJC Health comprises a group of committed rheumatologists and allied health professionals, working together to treat arthritis with a coordinated & integrated approach. Irwin utilizes social media including his blog to correct a general lack of awareness and misinformation about arthritis & rheumatic diseases. He is the author of “Stuff You Should Know about Rheumatoid Arthritis”, a resource to improve understanding of this disease. Disclosure: advisory boards for Abbvie, Pfizer, Roche, UCB, Novartis and Janssen.
Olga Petryna, MD: Dr. Olga Petryna is an attending rheumatologist at NYU Langone Faculty Group Practice. A summa cum laude graduate of the Ivano-Frankivsk Medical University in Ukraine, Dr. Petryna completed her Rheumatology Fellowship training at New York Presbyterian/Columbia Campus. Dr. Petryna has expertise in the treatment of autoimmune disorders including Rheumatoid Arthritis, Psoriatic arthritis, gout, Ankylosing Spondylitis, Sjogren’s syndrome, Vasculitis, Osteoporosis and Auto-inflammatory Syndromes. Dr. Petryna has published several papers in peer-reviewed journals and co-authored a book chapter. She can be followed on Twitter: @DrPetryna. Disclosure: Consultant for Celgene, Malinckrodt, Crescendo.
Janet Pope, MD: Dr. Pope is a Professor of Medicine at Western University, London, Ontario, Canada. She is a rheumatologist and epidemiologist and is Division Head in Rheumatology at St. Joseph’s Hospital, London, Ontario. She has a major interest in scleroderma including membership in the Canadian Scleroderma Research Group, Scleroderma Clinical Trials Consortium and co-leading the new ACR/EULAR guidelines for SSc, and has published over 250 peer reviewed articles. She was named the Canadian Rheumatology Association Distinguished Investigator in 2013 and Rheumatologist of the Year from the Ontario Rheumatology Association. She supervises students at all levels and runs two nationwide studentships for medical students to be exposed to clinical rheumatology or research in rheumatology.Disclosure: Consulting: AbbVie, Actelion, Amgen, Bayer, BMS, Hospira, Janssen, Lilly, Merck, Novartis, Pfizer, Roche, Sanofi, Sandoz, UCB. Research Grants: Amgen, Bayer, BMS, Merck, Pfizer, Roche, SeaGen, UCB.
Philip Robinson, MBChB PhD FRACP: Dr. Robinson is a rheumatologist in Brisbane, Australia. He completed his medical degree at Otago University in New Zealand and attained his PhD from the University of Queensland. His PhD was on the genetics of ankylosing spondylitis and anterior uveitis. Philip is still active in research in the areas of axial spondyloarthritis and gout. He currently works in public practice at the Royal Brisbane Hospital and in private practice at St Andrew’s Ware memorial Hospital. His website is www.brisbanerheumatology.com.a
William Shergy, MD: Dr. Shergy is Associate Clinical Professor of Medicine in the Depart- ment of Medicine at UAB School of Medicine. He is also Assistant Consulting Professor in the Department of Medicine at Duke University Medical Center in Durham, NC as well as a practicing Rheuma- tologist at Rheumatology Associates of North Alabama, PC. Disclosure: Biologic Cos and major Pharma for clinical trials and Speaker.
Paul Sufka, MD: Paul Sufka, MD is a rheumatologist and rheumatology department chair with HealthPartners and Regions Hospital in St. Paul, MN. He serves on the ACR communications and marketing committee, is involved in fellowship education with the University of Minnesota, and is one of the co-founders of the Rheumatology Journal Club on Twitter. He has also been involved in the use of technology in medicine, occasionally blogs at http://paulsufka.com, and is a health-tech startup advisor. Disclosure: Nothing to disclose.
Rachel Tate, DO: Dr. Tate is in clinical practice at Arthritis Care and Research Center and is a member of the Baylor Research Institute in Dallas, TX. Her areas of interest include patient advocacy, musculoskeletal ultrasound, pregnancy in connective tissue disease, and spondyloarthropathies. Disclosure: Speaker for Abbvie.
Douglas White, MD, PhD: Dr. White studied CD8 T cell biology at the University of Iowa before residency training at UT-Southwestern followed by a rheumatology fellowship and a virology post-doc at Washington University in St. Louis. He currently sees patients at Gundersen Health System in La Crosse, WI, oversees a herpesvirus mutagenesis lab and volunteers for the ACR. Disclosure: Nothing to disclose.